132 related articles for article (PubMed ID: 2180648)
1. Cytokine networks involved in the regulation of haemopoietic stem cell proliferation and differentiation.
Moore MA; Muench MO; Warren DJ; Laver J
Ciba Found Symp; 1990; 148():43-58; discussion 58-61. PubMed ID: 2180648
[TBL] [Abstract][Full Text] [Related]
2. Interactions among colony-stimulating factors, IL-1 beta, IL-6, and kit-ligand in the regulation of primitive murine hematopoietic cells.
Muench MO; Schneider JG; Moore MA
Exp Hematol; 1992 Mar; 20(3):339-49. PubMed ID: 1373685
[TBL] [Abstract][Full Text] [Related]
3. Cytokine-dependent long-term culture of highly enriched precursors of hematopoietic progenitor cells from human bone marrow.
Brandt J; Srour EF; van Besien K; Briddell RA; Hoffman R
J Clin Invest; 1990 Sep; 86(3):932-41. PubMed ID: 1697607
[TBL] [Abstract][Full Text] [Related]
4. The relationship between different high proliferative potential colony-forming cells in mouse bone marrow.
Kriegler AB; Verschoor SM; Bernardo D; Bertoncello I
Exp Hematol; 1994 May; 22(5):432-40. PubMed ID: 7513652
[TBL] [Abstract][Full Text] [Related]
5. Stem cell factor (c-kit ligand) enhances the interleukin-9-dependent proliferation of human CD34+ and CD34+CD33-DR- cells.
Lemoli RM; Fortuna A; Fogli M; Motta MR; Rizzi S; Benini C; Tura S
Exp Hematol; 1994 Aug; 22(9):919-23. PubMed ID: 7520394
[TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor beta and interleukin-1: a paradigm for opposing regulation of haemopoiesis.
Ruscetti FW; Dubois CM; Jacobsen SE; Keller JR
Baillieres Clin Haematol; 1992 Jul; 5(3):703-21. PubMed ID: 1333850
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-11 stimulates the proliferation of human hematopoietic CD34+ and CD34+CD33-DR- cells and synergizes with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factor.
Lemoli RM; Fogli M; Fortuna A; Motta MR; Rizzi S; Benini C; Tura S
Exp Hematol; 1993 Dec; 21(13):1668-72. PubMed ID: 7694867
[TBL] [Abstract][Full Text] [Related]
8. Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells.
Drexler HG
Leukemia; 1996 Apr; 10(4):588-99. PubMed ID: 8618433
[TBL] [Abstract][Full Text] [Related]
9. Combined measurement of growth and differentiation in suspension cultures of purified human CD34-positive cells enables a detailed analysis of myelopoiesis.
Kerst JM; Slaper-Cortenbach IC; von dem Borne AE; van der Schoot CE; van Oers RH
Exp Hematol; 1992 Nov; 20(10):1188-93. PubMed ID: 1385196
[TBL] [Abstract][Full Text] [Related]
10. Effects of anti-CD33 blocked ricin immunotoxin on the capacity of CD34+ human marrow cells to establish in vitro hematopoiesis in long-term marrow cultures.
La Russa VF; Griffin JD; Kessler SW; Cutting MA; Knight RD; Blattler WA; Lambert JM; Wright DG
Exp Hematol; 1992 May; 20(4):442-8. PubMed ID: 1373688
[TBL] [Abstract][Full Text] [Related]
11. Synergistic interactions in haemopoiesis: biological implications and clinical use.
Dexter TM
Eur J Cancer; 1993; 29A Suppl 3():S6-9. PubMed ID: 8398366
[TBL] [Abstract][Full Text] [Related]
12. Stimulation of granulopoiesis by transforming growth factor beta: synergy with granulocyte/macrophage-colony-stimulating factor.
Keller JR; Jacobsen SE; Sill KT; Ellingsworth LR; Ruscetti FW
Proc Natl Acad Sci U S A; 1991 Aug; 88(16):7190-4. PubMed ID: 1831268
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor-beta 1 delays formation of granulocyte-macrophage colony-forming cells, but spares more primitive progenitors during ex vivo expansion of CD34+ haemopoietic progenitor cells.
Garbe A; Spyridonidis A; Möbest D; Schmoor C; Mertelsmann R; Henschler R
Br J Haematol; 1997 Dec; 99(4):951-8. PubMed ID: 9432049
[TBL] [Abstract][Full Text] [Related]
14. A murine stromal cell line promotes the proliferation of the human factor-dependent leukemic cell line UT-7.
Auffray I; Dubart A; Izac B; Vainchenker W; Coulombel L
Exp Hematol; 1994 May; 22(5):417-24. PubMed ID: 7513651
[TBL] [Abstract][Full Text] [Related]
15. Stem cell factor and FLT3-ligand are strictly required to sustain the long-term expansion of primitive CD34+DR- dendritic cell precursors.
Curti A; Fogli M; Ratta M; Tura S; Lemoli RM
J Immunol; 2001 Jan; 166(2):848-54. PubMed ID: 11145659
[TBL] [Abstract][Full Text] [Related]
16. Synergy of interleukin 1 and granulocyte colony-stimulating factor: in vivo stimulation of stem-cell recovery and hematopoietic regeneration following 5-fluorouracil treatment of mice.
Moore MA; Warren DJ
Proc Natl Acad Sci U S A; 1987 Oct; 84(20):7134-8. PubMed ID: 3499607
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of the hematopoietic inhibitors MIP-1 alpha, TGF-beta, and TNF-alpha on cytokine-induced proliferation of subpopulations of CD34+ cells purified from cord blood and fetal liver.
Mayani H; Little MT; Dragowska W; Thornbury G; Lansdorp PM
Exp Hematol; 1995 May; 23(5):422-7. PubMed ID: 7536684
[TBL] [Abstract][Full Text] [Related]
18. Generation of a conditionally immortalized myeloid progenitor cell line requiring the presence of both interleukin-3 and stem cell factor to survive and proliferate.
Lee C; Evans CA; Spooncer E; Pierce A; Mottram R; Whetton AD
Br J Haematol; 2003 Sep; 122(6):985-95. PubMed ID: 12956770
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-4--a dual regulatory factor in hematopoiesis.
Sonoda Y
Leuk Lymphoma; 1994 Jul; 14(3-4):231-40. PubMed ID: 7950911
[TBL] [Abstract][Full Text] [Related]
20. In vitro differentiation and proliferation of human hematopoietic progenitors: the effects of interleukins 1 and 6 are indirectly mediated by production of granulocyte-macrophage colony-stimulating factor and interleukin 3.
Migliaccio G; Migliaccio AR; Adamson JW
Exp Hematol; 1991 Jan; 19(1):3-10. PubMed ID: 1989893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
